Our Mission
The ACC Nevada Chapter is dedicated to advancing the field of cardiovascular care through innovation, advocacy, and professional development, ensuring that Nevada’s clinicians are equipped to meet the evolving health challenges of our state.
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Please join our cardiology colleagues at the ACC Annual Meeting, a premier gathering of cardiovascular professionals from around the world. This dynamic conference brings together leading physicians, researchers, healthcare innovators, and industry experts to explore the latest advances in cardiovascular medicine. Attendees will experience cutting-edge clinical education, groundbreaking research presentations, interactive learning sessions, and exceptional networking opportunities focused on improving patient care and advancing the future of heart health.
Latest in Cardiology from ACC.org
- Whole-Grain Intake Tied to Improved Cardiometabolic Risk Factors in Meta-AnalysisHigher whole-grain intake was associated with improvements in multiple cardiometabolic risk factors in a meta-analysis of randomized trials published Sept. 15 in EHJ. The largest effects were generally seen at whole-grain intakes of about 60-100 g/day.
- Beyond Calcium: CTA Plaque Characteristics in South Asian Patients in the DILWALE RegistrySouth Asian (SA) individuals experience a disproportionate burden of premature atherosclerotic cardiovascular disease (ASCVD), and this excess risk is not fully explained by traditional risk factors.
- ACC Quality Summit Abstract Winners Explore AUC Discrepancies, Sex Differences in LAAO Outcomes, SDOH ScreeningWith a record-breaking number of abstract submissions, the quality improvement projects presented at ACC Quality Summit 2026 reflect an ongoing commitment to improve cardiovascular care through innovation, collaboration and quality. Read on for highlights from the top ePosters.
- ACC CardiaCast: Future Directions in ATTR-CM TreatmentIn this CardiaCast episode, Kevin M. Alexander, MD is joined by Sarah Cuddy, MBBCh, to discuss the latest clinical data for investigational therapies and available treatments for transthyretin amyloid cardiomyopathy (ATTR-CM), as well as the potential implications of these findings on clinical practice and future clinical studies.
- ACC Names ACC.28 and ACC.29 CV Team LeadThe ACC has named Maureen Knechtel, DMSc, PA-C, as the Annual Scientific Session Cardiovascular (CV) Team Lead for ACC.28 and ACC.29. In her new role, she will help guide the development of educational content and programming that highlights the vital contributions of the entire cardiovascular care team and supports interprofessional collaboration across the ACC community.